In colorectal cancer (CRC), high PRDX1 expression correlates with tumor invasiveness, metastasis, and chemotherapy resistance, and its role in immune evasion and chemotherapy resistance makes it a potential therapeutic target (Song et al., 2024). The gene discussed is PRDX1; the disease is neoplasm.